Key result
Aging, incident myocardial infarction, and cardiac remodeling were strong determinants of significant 10-year increases in BNP and NT-proBNP levels in the general population (P<0.001).
Why the study?
What are the clinical and echocardiographic determinants of long-term changes in BNP and NT-proBNP in the general population?
Cohort (n=877)
What are the clinical and echocardiographic determinants of long-term changes in BNP and NT-proBNP in the general population?
Long-term changes in BNP and NT-proBNP in the general population are driven not only by age and sex, but significantly by incident cardiac events, cardiac remodeling, and metabolic factors like diabetes and BMI.
Incident MI and remodeling may inform serial natriuretic peptide interpretation; hypothesis-generating for targeted interventions in general populations.
AIMS: The natriuretic peptides BNP and NT-proBNP are potent cardiac markers, but knowledge of long-term changes is sparse. We thus quantified determinants of change in BNP and NT-proBNP in a study of south German residents (KORA). METHODS AND RESULTS: A total of 1005 men and women (age 25-74 years, mean 48 years) underwent physical examination and echocardiography at baseline and at follow-up after 10 years. The current analysis comprised 877 subjects with dual measurements of BNP and NT-proBNP. Both markers increased in both sexes (P < 0.001) during the 10-year follow-up, and higher levels in women persisted across time (P for sex difference <0.001). Among baseline covariates, predictors for 10-year change of NT-proBNP, BNP, or both were age, sex, diabetes status, and heart rate (multivariable regression analysis, each P < 0.05). However, changes of covariates over the 10-year follow-up were much stronger determinants. Specifically, incident myocardial infarction, new beta-blocker medication, and increased cardiac parameters (left atrial diameter, LV end-diastolic diameter, and LV mass index) were associated with increasing BNP, NT-proBNP, or both, whereas increased heart rate, haematocrit, and body mass index (BMI) were associated with decreasing BNP and NT-proBNP (all P < 0.05). CONCLUSION: Next to ageing and sex, a variety of changes in covariates reflecting the sequelae of cardiac remodelling as well as myocardial infarction and diabetes influence long-term changes of BNP and NT-proBNP. Of note, diabetes and increased BMI exert opposite effects. For interpretation of individual marker concentrations, a host of covariates needs to be considered, especially in subjects without prevalent or incident cardiac disease.
No takes yet. Share an insight, caveat, or question.
Luchner et al. (2013) conducted a cohort in General population (n=877). Observation of clinical and echocardiographic determinants was evaluated on 10-year change in BNP and NT-proBNP (p=<0.001). Aging, incident myocardial infarction, and cardiac remodeling were strong determinants of significant 10-year increases in BNP and NT-proBNP levels in the general population (P<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: